Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 3/20 | 0.78 |
| ▸ | ECE1 | P42892 | 12/20 | 0.72 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9235801 | 1.00 | ACE (0.78) | ACEECE1ALOX15 | |
| SCHEMBL9235805 | 1.00 | ACE (0.78) | ACEECE1ALOX15 | |
| SCHEMBL1228369 | 1.00 | ACE (0.78) | ACEECE1ALOX15 | |
| SCHEMBL2488765 | 1.00 | ACE (0.78) | ACEECE1ALOX15 | |
| SCHEMBL30051087 | 0.98 | ACE (0.75) | ACEECE1ALOX15 | |
| SCHEMBL30051627 | 0.95 | ACE (0.72) | ACEECE1ALOX15 | |
| SCHEMBL3497589 | 0.95 | ACE (0.72) | ACEECE1ALOX15 | |
| SCHEMBL4959992 | 0.93 | ERAP2 (0.75) | ACEECE1 | |
| SCHEMBL4959976 | 0.93 | ERAP2 (0.75) | ACEECE1 | |
| SCHEMBL30052301 | 0.93 | ACE (0.69) | ACEECE1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260069651-A1 | Application of Sardine Peptide Composition in Drug for Treating Allergic Rhinitis | HAIKOU QIAOSHUI UNITED TECHNOLOGY CO. LTD. (CN) | 2026-03-12 | — | — | US | claimed |
| EP-4695413-A1 | PHOSPHONOALANINE OLIGOPEPTIDES AND METHODS OF MAKING AND USE THEREOF | Ohio State Innovation Foundation (US) | 2026-02-18 | — | — | EP | claimed |
| EP-4384540-B1 | BIOMIMETIC PEPTIDES AND THEIR USE IN BONE REGENERATION | KLISBIO S R L (IT) | 2025-08-06 | — | — | EP | claimed |
| CN-119899236-A | Phenylalanine-tryptophan dipeptide framework mesoporous silicon material, and preparation method and application thereof | 南京工业大学 | 2025-04-29 | — | — | CN | claimed |
| US-20250129123-A1 | BIOMIMETIC PEPTIDES AND THEIR USE IN BONE REGENERATION | SILK BIOMATERIALS S.R.L. (IT) | 2025-04-24 | — | — | US | claimed |
| CN-118987163-A | Use of sardine peptide-containing composition for improving atopic dermatitis symptoms | 海口桥水联合科技有限责任公司 | 2024-11-22 | — | — | CN | claimed |
| WO-2024235082-A1 | USE OF SARDINE PEPTIDE COMPOSITION IN DRUG FOR TREATING ALLERGIC RHINITIS | 海口桥水联合科技有限责任公司 | 2024-11-21 | — | — | WO | claimed |
| WO-2024216031-A1 | PHOSPHONOALANINE OLIGOPEPTIDES AND METHODS OF MAKING AND USE THEREOF | OHIO STATE INNOVATION FOUNDATION (US) | 2024-10-17 | — | — | WO | claimed |
| CN-118688315-A | Multichannel high-coverage synchronous quantification method for amino-containing and hydroxyl-containing compounds | 复旦大学 | 2024-09-24 | — | — | CN | claimed |
| US-12097237-B2 | Small molecule Ras inhibitors | OHIO STATE INNOVATION FOUNDATION (US) | 2024-09-24 | — | — | US | claimed |
| EP-4384540-A1 | BIOMIMETIC PEPTIDES AND THEIR USE IN BONE REGENERATION | Silk Biomaterials S.r.l. (IT) | 2024-06-19 | — | — | EP | claimed |
| CN-117999277-A | Bionic peptides and their use in bone regeneration | 西尔克生物材料有限公司 | 2024-05-07 | — | — | CN | claimed |
| CN-116350746-B | Application of sardine peptide composition in medicines for treating allergic rhinitis | 海口桥水联合科技有限责任公司 | 2024-03-22 | — | — | CN | claimed |
| CN-116735770-A | Synchronous quantitative detection method for multiple metabolites in biological sample | 复旦大学 | 2023-09-12 | — | — | CN | claimed |
| CN-116350746-A | Application of sardine peptide composition in medicines for treating allergic rhinitis | 海口桥水联合科技有限责任公司 | 2023-06-30 | — | — | CN | claimed |
| WO-2023016904-A1 | BIOMIMETIC PEPTIDES AND THEIR USE IN BONE REGENERATION | SILK BIOMATERIALS S.R.L. (IT) | 2023-02-16 | — | — | WO | claimed |
| CN-115677845-A | Method for preparing somaglutide by dipeptide feeding at specific site | 前沿生物药业(南京)股份有限公司 | 2023-02-03 | — | — | CN | claimed |
| US-12622975-B2 | Peptide-conjugated prodrugs | BRANDEIS UNIVERSITY (US) | 2026-05-12 | — | — | US | disclosed |
| WO-2022050529-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | ㈜베르티스 | 2022-03-10 | — | — | WO | disclosed |
| EP-3962518-A1 | IMMUNOGEN FOR PREVENTING OR TREATING FAMILIAL FRONTOTEMPORAL DEMENTIA (FTD) AND/OR AMYOTROPHIC LATERAL SCLEROSIS (ALS) | Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE) (DE) | 2022-03-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12097237-B2 | Small molecule Ras inhibitors | KRAS, HRAS, NRAS | ACE 686/4885ECE1 2148/4885ALOX15 4077/4885 |
| US-12622975-B2 | Peptide-conjugated prodrugs | PEPD, PAM, VIP | ACE 1190/4885ECE1 1629/4885ALOX15 4573/4885 |
| US-20260069651-A1 | Application of Sardine Peptide Composition in Drug for Treating Allergic Rhinitis | VIP, ANPEP, RNPEP | ACE 132/4885ECE1 363/4885ALOX15 3007/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.